Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.

Krogstad V, Vethe NT, Robertsen I, Hasvold G, Ose AD, Hermann M, Andersen AM, Chan J, Skauby M, Svensson MHS, Åsberg A, Christensen H.

Ther Drug Monit. 2018 Jun;40(3):292-300. doi: 10.1097/FTD.0000000000000510.

PMID:
29578937
2.

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.

Mori Y, Kasai H, Ose A, Serada M, Ishiguro M, Shiraki M, Tanigawara Y.

Osteoporos Int. 2018 May;29(5):1155-1163. doi: 10.1007/s00198-018-4376-1. Epub 2018 Feb 8.

3.

Population Pharmacokinetic and Exposure-Response Analysis of Weekly Teriparatide in Osteoporosis Patients.

Ose A, Serada M, Yamashita K, Tsurui K, Tanigawara Y.

J Clin Pharmacol. 2017 Dec;57(12):1545-1553. doi: 10.1002/jcph.949. Epub 2017 Jun 14.

PMID:
28614613
4.

Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802.

Ito M, Kusuhara H, Ose A, Kondo T, Tanabe K, Nakayama H, Horita S, Fujita T, Sugiyama Y.

AAPS J. 2017 Jan;19(1):286-297. doi: 10.1208/s12248-016-9992-0. Epub 2016 Oct 31.

PMID:
27800573
5.

Development of a Support Vector Machine-Based System to Predict Whether a Compound Is a Substrate of a Given Drug Transporter Using Its Chemical Structure.

Ose A, Toshimoto K, Ikeda K, Maeda K, Yoshida S, Yamashita F, Hashida M, Ishida T, Akiyama Y, Sugiyama Y.

J Pharm Sci. 2016 Jul;105(7):2222-30. doi: 10.1016/j.xphs.2016.04.023. Epub 2016 Jun 1.

PMID:
27262201
6.

[Inhibition of aflatoxin production and fungal growth on stored corn by allyl isothiocyanate vapor].

Okano K, Ose A, Takai M, Kaneko M, Nishioka C, Ohzu Y, Odano M, Sekiyama Y, Mizukami Y, Nakamura N, Ichinoe M.

Shokuhin Eiseigaku Zasshi. 2015;56(1):1-7. doi: 10.3358/shokueishi.56.1. Japanese.

7.

Automated extraction of information on chemical-P-glycoprotein interactions from the literature.

Yoshida S, Yamashita F, Ose A, Maeda K, Sugiyama Y, Hashida M.

J Chem Inf Model. 2013 Oct 28;53(10):2506-10. doi: 10.1021/ci4003188. Epub 2013 Sep 24.

PMID:
24010770
8.

Relationship between the urinary excretion mechanisms of drugs and their physicochemical properties.

Ito S, Ando H, Ose A, Kitamura Y, Ando T, Kusuhara H, Sugiyama Y.

J Pharm Sci. 2013 Sep;102(9):3294-301. doi: 10.1002/jps.23599. Epub 2013 May 27.

PMID:
23712676
9.

Aflatoxins B and g contamination and aflatoxigenic fungi in nutmeg.

Okano K, Tomita T, Ohzu Y, Takai M, Ose A, Kotsuka A, Ikeda N, Sakata J, Kumeda Y, Nakamura N, Ichinoe M.

Shokuhin Eiseigaku Zasshi. 2012;53(5):211-6. Japanese.

10.

Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.

Ose A, Kusuhara H, Endo C, Tohyama K, Miyajima M, Kitamura S, Sugiyama Y.

Drug Metab Dispos. 2010 Jan;38(1):168-76. doi: 10.1124/dmd.109.029454.

PMID:
19833843
12.

Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds.

Enokizono J, Kusuhara H, Ose A, Schinkel AH, Sugiyama Y.

Drug Metab Dispos. 2008 Jun;36(6):995-1002. doi: 10.1124/dmd.107.019257. Epub 2008 Mar 5.

PMID:
18322075
13.

P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.

Ose A, Kusuhara H, Yamatsugu K, Kanai M, Shibasaki M, Fujita T, Yamamoto A, Sugiyama Y.

Drug Metab Dispos. 2008 Feb;36(2):427-34. Epub 2007 Nov 26.

PMID:
18039806
14.

Diclofenac-induced inactivation of CYP3A4 and its stimulation by quinidine.

Masubuchi Y, Ose A, Horie T.

Drug Metab Dispos. 2002 Oct;30(10):1143-8.

PMID:
12228192
15.

Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis.

Jishage K, Nezu J, Kawase Y, Iwata T, Watanabe M, Miyoshi A, Ose A, Habu K, Kake T, Kamada N, Ueda O, Kinoshita M, Jenne DE, Shimane M, Suzuki H.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8903-8. Epub 2002 Jun 11.

16.

Differential selectivity in carbamazepine-induced inactivation of cytochrome P450 enzymes in rat and human liver.

Masubuchi Y, Nakano T, Ose A, Horie T.

Arch Toxicol. 2001 Nov;75(9):538-43.

PMID:
11760814
17.

Mechanism-based inactivation of CYP2C11 by diclofenac.

Masubuchi Y, Ose A, Horie T.

Drug Metab Dispos. 2001 Sep;29(9):1190-5.

PMID:
11502726
18.

[Functional activity of the nucleolar organizer in the interphase granulocytic nuclei in chronic myeloid leukemia].

Petushkov VI, Strozha IL, Bondare DK, Mironova NA, Voskoboĭnik NI, Ose AIa.

Arkh Patol. 1994 Mar-Apr;56(2):28-30. Russian.

PMID:
8037588
19.

[Study of polymorphism in human rRNA gene clusters. Population and familial analysis of basic types of RFLP].

Skriabin BV, Voskoboĭnik NI, Ose AIa, Gindilis VM.

Genetika. 1989 Aug;25(8):1488-98. Russian.

PMID:
2573559
20.

[Health care services for patients with angina pectoris. An evaluation of diagnosis and treatment at a regional hospital].

Nordby A, Frøland G, Ose A, Saeterhaug A.

Tidsskr Nor Laegeforen. 1983 Aug 20;103(23):1634-7. Norwegian. No abstract available.

PMID:
6636074

Supplemental Content

Support Center